Additional pancreatitis-associated mutations are located in CFTR, CPA1 and SPINK1, but lesser risk seems associated with variants in CTRC and CASR. As sequence changes as well as copy-number variants have been associated with an elevated pancreatitis risk, genetic testing should consist of full exome sequencing and deletion or duplication analysis. This evidence concerns the gene CASR and pancreatitis.